Drug – bio-affecting and body treating compositions – Antigen – epitope – or other immunospecific immunoeffector – Parasitic organism or component thereof or substance...
Patent
1975-04-17
1976-03-30
Moyer, Donald B.
Drug, bio-affecting and body treating compositions
Antigen, epitope, or other immunospecific immunoeffector
Parasitic organism or component thereof or substance...
424327, 71 67, 162161, A01N 912, A01N 902
Patent
active
039475816
ABSTRACT:
The present invention relates to certain processes and compositions useful for inhibiting the growth of slime in water and, in particular, water used for industrial purposes; for example, in the manufacture of pulp paper, in the manufacture of paper, in cooling water systems and in effluent water treatment. The novel processes and compositions of the present invention are processes or mixtures which show unexpected synergistic activity against microorganisms, including bacteria, fungi, and algae, which produce slime in aqueous systems or bodies which are objectionable from either an operational or aesthetic point of view. Specifically, the invention is directed to the use of compositions comprising a combination 1,3-dichloroacetone oxime acetate and a mixture of 75% of 5-chloro-2-methyl-4-isothiazolin-3-one calcium chloride and 25% of 2-methyl-4-isothiazolin-3-one calcium chloride.
REFERENCES:
patent: 3733419 (1973-08-01), Altman
patent: 3896229 (1975-07-01), Shema et al.
patent: 3903279 (1975-09-01), Swered et al.
patent: 3903296 (1975-09-01), Swered et al.
patent: 3904764 (1975-09-01), Swered et al.
Michael Dana U.
Swered Paul
Betz Laboratories Inc.
Moyer Donald B.
Ricci Alexander D.
LandOfFree
Synergistic compositions containing 1,3-dichloroacetone oxime ac does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Synergistic compositions containing 1,3-dichloroacetone oxime ac, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Synergistic compositions containing 1,3-dichloroacetone oxime ac will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-521785